tiprankstipranks
Chemed Corporation (DE:CXM)
FRANKFURT:CXM

Chemed Stock Price & Analysis

0 Followers

CXM Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range― - ―
Previous Close€460
Volume0.00
Average Volume (3M)7.00
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)€9.64M
Total Debt (Recent Filing)€132.12M
P/E RatioN/A
Beta0.58
Next EarningsNov 02, 2022
Dividend Yield1.46 (0.32%)
EPS (TTM)N/A
Shares Outstanding14,904,946
R-SquaredN/A
Standard DeviationN/A
10 Day Avg. Volume0
30 Day Avg. Volume7
P/B Ratio4582.51
P/S Ratio3.19
P/CF Ratio20.80
P/FCF Ratio25.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside22.11% Upside
Rating ConsensusModerate Buy
AlphaN/A
Number of Analyst Covering1


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

CXM FAQ

What was Chemed’s price range in the past 12 months?
Currently, no data Available
What is Chemed’s market cap?
Currently, no data Available
When is Chemed’s upcoming earnings report date?
Chemed’s upcoming earnings report date is Nov 02, 2022 which is in 36 days.
    How were Chemed’s earnings last quarter?
    Chemed released its earnings results on Jul 27, 2022. The company reported €5.025 earnings per share for the quarter, beating the consensus estimate of €4.96 by €0.065.
      Is Chemed overvalued?
      According to Wall Street analysts Chemed’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Chemed pay dividends?
        Chemed pays a Quarterly dividend of €0.39 which represents an annual dividend yield of 0.32%. Chemed’s last Quarterly dividend payment was on Sep 02, 2022. Chemed’s upcoming ex-dividend date is Aug 12, 2022
          What is Chemed’s EPS estimate?
          Chemed’s EPS estimate is €4.83.
            How many shares outstanding does Chemed have?
            Currently, no data Available
            What happened to Chemed’s price movement after its last earnings report?
            Chemed reported an EPS of €5.025 in its last earnings report, beating expectations of €4.96. Following the earnings report the stock price went down -5.743%.
              Which hedge fund is a major shareholder of Chemed?
              Among the largest hedge funds holding Chemed’s share is Fisher Asset Management LLC. It holds Chemed’s shares valued at 68M.

                ---

                Chemed Stock Analysis

                Smart ScoreNeutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                7
                The Chemed Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Chemed Corporation

                Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the following segments: VITAS and Roto-Rooter. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                CVS Health
                Cigna
                Laboratory
                Quest Diagnostics
                R1 RCM

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis